Anavex Life Sciences
AVXL
AVXL
58 hedge funds and large institutions have $53.8M invested in Anavex Life Sciences in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
0% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 18
2% less funds holding
Funds holding: 59 → 58 (-1)
83% less call options, than puts
Call options by funds: $1.34M | Put options by funds: $7.66M
Holders
58
Holding in Top 10
1
Calls
$1.34M
Puts
$7.66M
Top Buyers
| 1 | +$9.21M | |
| 2 | +$8.39M | |
| 3 | +$985K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$762K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$431K |
Top Sellers
| 1 | -$503K | |
| 2 | -$325K | |
| 3 | -$246K | |
| 4 |
Citigroup
New York
|
-$165K |
| 5 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
-$129K |